Uncategorized Archives - Page 39 of 251

WednesdayJul 20, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pending Start of Human Nicotine Study, NIC-H22-1, Leveraging Fast-Growing Global Nicotine Pouches Market

Lexaria Bioscience Corp. expects the upcoming human nicotine study to produce evidence that its patented DehydraTECH(TM) technology can enhance oral-tissue absorption with reduced negative experiences Data collected from animal study NIC-A21-1 showed that DehydraTECH enhanced oral nicotine pouches delivered peak nicotine levels in the bloodstream of animals 10x to 20x faster than the control The global nicotine pouches market was valued at $2.33 billion in 2020 and is expected to reach $21.84 billion by 2027, being one of the fastest growing segments in the nicotine industry Lexaria's pipeline addresses serious unmet patient or consumer needs with greater market potential, addressing…

WednesdayJul 20, 2022 4:20 am

420 with CNW — The Marijuana Drinks Segment Looks Poised for Long-Term Growth

We have seen several major players enter the marijuana drink market in the recent past as more products are launched, despite the segment being in its infancy. While the focus in the past had been THC-infused drinks, we have seen interest in the wellness benefits linked to CBD growing as well. Cannabis drinks are popular with consumers for various reasons, including fewer health concerns, discreetness, ease of consumption and less stigma when compared to other marijuana consumption methods such as smoking. These drinks also have faster onset of effects as the cannabinoids are quickly absorbed into an individual’s bloodstream under…

MondayJul 18, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Best-In Class Solution To Major Issue Affecting A Range Of Critical Drug Applications

Researchers have run into the issue of solubility of molecules intended for absorption, ultimately affecting drug effectiveness and inhibiting patient recovery This has forced the exploration of new drug delivery technologies, with Lexaria’s patented DehydraTECH(TM) technology proving to be the most innovative, useful, and effective DehydraTECH(TM) technology has seen application in oral nicotine for reduced risk, antiviral drugs for COVID-19 and other infectious diseases, PDE5 inhibitors, and CBD for hypertension The recent expansion of the Cannadips Brand into Europe, Japan, and South Africa highlights the proliferation of DehydraTECH and a significant growth in its market share, particularly in the CBD…

ThursdayJul 14, 2022 4:20 pm

420 with CNW — Connecticut Company Leverages DEA License to Supply Marijuana for Yale Research

CT Pharma, a Connecticut-based medical marijuana production and research company, made history in 2019 when the U.S. Drug Enforcement Administration allowed it to grow marijuana for FDA-approved research. It became the first state-licensed cannabis company that could legally provide cannabis for studies funded by the federal government, breaking the University of Mississippi’s monopoly on cultivating research-grade cannabis. The university had been the only federally approved supplier of cannabis for years. Still, researchers regularly complained that the cannabis produced by the facility was low-grade and compromised the results of their studies. In a move that is sure to be approved by…

ThursdayJul 14, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH(TM) Licensee Expands Manufacturing Agreements to Include Europe, Japan, and South Africa

Lexaria's patented DehydraTECH(TM) enhancement technology targets key market segments including nicotine replacement, CBD, cardiovascular and antiviral drugs, human hormones, and PDE5 inhibitors DehydraTECH-enabled drug and consumer products provide faster delivery times, increased bioavailability, increased brain absorption, improved drug potency, lower administration costs, and mask unwanted tastes The global CBD market was valued at $5.18 billion in 2021 and is expected to grow at a CAGR of 16.8% from 2022 to 2030, resulting in a revenue forecast of $22.05 billion by 2030 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has announced that Boldt Runners Corporation, licensee of…

WednesdayJul 13, 2022 4:20 am

420 with CNW — Marijuana Consumption Lounges May Open in Nevada by Year’s End

Adults aged 21 and older in Nevada may soon be able to use cannabis products publicly in cannabis consumption lounges by the end of the year after the Cannabis Compliance Board approved regulations for the consumption sites. Although Nevada launched the recreational cannabis market back in 2017, the state only allows adults to consume the substance in private homes. This is despite the fact that Nevada’s cannabis industry has been a big draw for tourists, with plenty of visitors coming from out of state to sample products from cannabis retailers in Las Vegas. The result is that tourists are allowed…

TuesdayJul 12, 2022 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Enhances Bioavailability of Orally Administered APIs

Lexaria is a global innovator in drug delivery platforms The company has developed the patented DehydraTECH(TM) technology that significantly improves the bioavailability of orally administered pharmaceuticals and therapeutics Bioavailability is the fraction of a drug that reaches the site of action or systemic circulation While drugs delivered intravenously are 100% bioavailable, drugs that have any other route of administration, such as oral, have reduced bioavailability DehydraTECH enhances the bioavailability of APIs, in part, by bypassing first-pass liver processing Global innovator Lexaria Bioscience (NASDAQ: LEXX) has built a reputation as a developer of drug delivery platforms, the most notable of which…

MondayJul 11, 2022 10:30 am

Flora Growth Corp.’s (NASDAQ: FLGC) Shareholders Vote in Favor of All Proposals Submitted for Approval; Elect Brandon Konigsberg to Board of Directors

Shareholders approve all proposals submitted at this year’s annual shareholders’ meeting, including board members Among the seven members of the Board of Directors elected, six were incumbents, making Brandon Konigsberg the newest addition to the Board Mr. Konigsberg will lend his years of experience, having held key leadership positions in various organizations in the country Luis Merchan, Flora Growth’s Chairman and CEO, noted that Mr. Konigsberg’s appointment would help the organization achieve rapid financial growth and maximize shareholder value Annual shareholders’ meetings are usually landmark moments of shareholder democracy, offering shareholders an opportunity to participate in the company’s decisions and…

FridayJul 08, 2022 4:20 pm

420 with CNW — Governor Newsom Signs Bill Easing California’s Cannabis Taxes

More than five years after California legalized recreational cannabis, the state’s illicit cannabis market still makes up a majority of recreational cannabis sales. For example, in 2019, illicit cannabis sales reached around $8.7 billion while the legal market sold $3.1 billion worth of cannabis. Governor Gavin Newsom has now signed a bill that would restructure California’s recreational cannabis program in an effort to combat illegal sales. Bill AB 195 will get rid of the marijuana cultivation tax and require that the excise tax not increase for the next three years, reducing the financial load on cannabis producers and theoretically allowing…

WednesdayJul 06, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Production Capabilities to Support Growing List of Business-to-Business Clientele

Lexaria is a global innovator in drug delivery platforms; its patented DehydraTECH(TM) technology improves the bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“API”) Testing confirms that DehydraTECH-processed cannabidiol beverages maintained 93.4% and 78% potency of CBD a full year and two years after production, respectively Lexaria recently signed two agreements with BevNology LLC, an Atlanta-based company with advanced capabilities that support best-in-class beverage formulations The partnership, which also leverages Lexaria’s superior DehydraTECH-CBD nanoemulsification formulation and processing techniques, could make industry-leading beverage products a reality for many brands In this year’s letter to shareholders, Lexaria Bioscience (NASDAQ:…